Qunfeng Fu

545 total citations
11 papers, 415 citations indexed

About

Qunfeng Fu is a scholar working on Biomedical Engineering, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Qunfeng Fu has authored 11 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 6 papers in Organic Chemistry and 4 papers in Molecular Biology. Recurrent topics in Qunfeng Fu's work include Nanoplatforms for cancer theranostics (8 papers), Click Chemistry and Applications (6 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Qunfeng Fu is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Click Chemistry and Applications (6 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Qunfeng Fu collaborates with scholars based in China, Ethiopia and Vietnam. Qunfeng Fu's co-authors include Zhibo Liu, Zhibin Guo, Ziyang Wang, Zexuan Ding, Dongban Duan, Huimin Ma, Hongyu Li, Junyi Chen, Mengxin Xu and Yuxiang Han and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Qunfeng Fu

11 papers receiving 415 citations

Peers

Qunfeng Fu

BE

OC

MB

MC

RNMI

Zexuan Ding China

Chuan-Lin Chen Taiwan

Fernando Cortezon‐Tamarit United Kingdom

Zhiwei Sun China

Yinxing Miao China

Shey-Cherng Tzou Taiwan

Dongban Duan China

Haipeng Zhang China

Yalan Tu China

Lloyd Hamilton United Kingdom

Zexuan Ding China

Qunfeng Fu

147 ×0.8

BE

93 ×0.6

OC

102 ×0.7

MB

83 ×0.9

MC

49 ×0.7

RNMI

Citations per year, relative to Qunfeng Fu Qunfeng Fu (= 1×) peers Zexuan Ding

Countries citing papers authored by Qunfeng Fu

Since Specialization

Citations

This map shows the geographic impact of Qunfeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunfeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunfeng Fu more than expected).

Fields of papers citing papers by Qunfeng Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunfeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunfeng Fu. The network helps show where Qunfeng Fu may publish in the future.

Co-authorship network of co-authors of Qunfeng Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Qunfeng Fu. A scholar is included among the top collaborators of Qunfeng Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunfeng Fu. Qunfeng Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Fu, Qunfeng, Shuren Zhang, Junyi Chen, et al.. (2024). Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours. Nature Biomedical Engineering. 8(11). 1425–1435. 28 indexed citations

2.

Fu, Qunfeng, et al.. (2024). Radiotherapy activates picolinium prodrugs in tumours. Nature Chemistry. 16(8). 1348–1356. 42 indexed citations

3.

Guo, Zhibin, Yi Han, Peng Tian, et al.. (2024). Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis. ACS Central Science. 10(12). 2321–2330. 7 indexed citations

4.

Fu, Qunfeng, et al.. (2023). Bioorthogonal chemistry for prodrug activation in vivo. Chemical Society Reviews. 52(22). 7737–7772. 80 indexed citations

5.

Guo, Zhibin, et al.. (2022). Radiotherapy‐Induced Cleavage of Quaternary Ammonium Groups Activates Prodrugs in Tumors. Angewandte Chemie International Edition. 61(34). e202205014–e202205014. 49 indexed citations

6.

Ding, Zexuan, et al.. (2022). Radiotherapy Reduces N-Oxides for Prodrug Activation in Tumors. Journal of the American Chemical Society. 144(21). 9458–9464. 76 indexed citations

7.

Guo, Zhibin, et al.. (2022). Radiotherapy‐Induced Cleavage of Quaternary Ammonium Groups Activates Prodrugs in Tumors. Angewandte Chemie. 134(34). 13 indexed citations

8.

Duan, Dongban, Hao Dong, Chunhong Wang, et al.. (2021). Desilylation Induced by Metal Fluoride Nanocrystals Enables Cleavage Chemistry In Vivo. Journal of the American Chemical Society. 143(5). 2250–2255. 21 indexed citations

9.

Fu, Qunfeng, et al.. (2020). External‐Radiation‐Induced Local Hydroxylation Enables Remote Release of Functional Molecules in Tumors. Angewandte Chemie. 132(48). 21730–21736. 12 indexed citations

10.

Fu, Qunfeng, et al.. (2020). External‐Radiation‐Induced Local Hydroxylation Enables Remote Release of Functional Molecules in Tumors. Angewandte Chemie International Edition. 59(48). 21546–21552. 69 indexed citations

11.

Liu, Hui, Yuxiang Han, Jiyuan Li, et al.. (2018). ¹⁸F-Alanine Derivative Serves as an ASCT2 Marker for Cancer Imaging. Molecular Pharmaceutics. 15(3). 947–954. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact